Centene Corporation
CNC Details
Centene Corporation (NYSE: CNC) is a multi-national healthcare company that participates in government-sponsored and commercial healthcare programs to cater to under-insured and uninsured individuals. Its revenue-generating segments include 1) Managed Care segment, focused on providing health plans, including all of the functions required to operate them, and 2) Specialty Services segment, comprising supplementary healthcare products and services. As of November 15, 2021, CNC’s market capitalization stood at USD 43.82 billion.
Latest News:
Q3FY21 Results:
Key Risks:
Outlook:
Valuation Methodology: EV/EBITDA Multiple Based Relative Valuation
(Analysis by Kalkine Group)
* % Premium/(Discount) is based on our assessment of the company's NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
CNC Daily Technical Chart (Source: REFINITIV)
Stock Recommendation:
CNC's stock price has increased by 29.06% in the past nine months and is currently close to the higher end of its 52-week range of USD 57.16 to USD 76.17. The stock is currently trading above its 50 and 200 DMA levels, and its RSI Index is 67.67, indicating an overbought zone. We have valued the stock using the EV/EBITDA-based relative valuation methodology and arrived at a target price of USD 71.06.
Considering the significant uptick in the stock price and other technical indicators, we believe the decent business fundamentals are sufficiently reflected at current trading levels. Hence, we recommend a "Sell" rating on the stock at the closing price of USD 75.10, down 1.00% as of November 15, 2021.
* All forecasted figures and Industry Information have been taken from REFINITIV.
* The reference data in this report has been partly sourced from REFINITIV.
The St. Joe Company
JOE Details
The St. Joe Company (NYSE: JOE) is a Northwest Florida-based real estate development, asset management, and operating company. The company is focused on increasing the value of its real estate assets by constructing residential, commercial, and hospitality buildings. Nearly 86 percent of JOE's real estate is located in Florida's Bay, Gulf, and Walton Counties. In addition, approximately 90 percent of its property holdings are within 15 miles of the United States Gulf of Mexico. As of November 15, 2021, the company’s market capitalization stood at USD 3.12 billion.
Latest News:
Q3FY21 Results:
Key Risks:
JOE Daily Technical Chart (Source: REFINITIV)
Stock Recommendation:
JOE's share price has increased 72.11% in the past twelve months and is currently leaning towards the higher end of its 52-week range of USD 29.84 to USD 57.55. The stock is currently trading above its 50 and 200 DMA levels, and its RSI Index is at 72.04, representing an overbought zone.
Considering the significant uptick in the stock price and other technical indicators, we believe the solid business fundamentals are adequately reflected the current trading levels. Hence, we recommend a "Sell" rating on the stock at the closing price of USD 52.94, down 1.08% as of November 15, 2021.
*All forecasted figures and Industry Information have been taken from REFINITIV.
*The reference data in this report has been partly sourced from REFINITIV.
Disclaimer
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.